Lupin receives US FDA approval for Loteprednol Etabonate Ophthalmic Suspension, 0.2 per cent – ET HealthWorld | Pharma

Lupin receives US FDA approval for Loteprednol Etabonate Ophthalmic Suspension, 0.2 per cent – ET HealthWorld | Pharma
Mumbai: Lupine Limited announced that it has received approval from the United States Food and Drug Administration (US FDA) for ...
Read more